Provide services such as process technology transfer, trade, project services and MAH registration for mAb/gene recombination enterprises; from project establishment to conceptual design, engineering detailed design, key process system manufacturing, automation control material procurement, engineering implementation, installation and commissioning, verification , digital factory, after-sales training and other EPC general contracting services.
Product coverage: adalimumab, bevacizumab, nivolumab, trastuzumab, rituximab, denosumab, ipilimumab, panitumumab, exenatide, Recombinant albumin, recombinant human insulin, insulin glargine, insulin aspart, liraglutide, dulaglutide, insulin degludec, etc.。